Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0001689813-19-000063
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-09-13 16:34:52
Reporting Period:
2019-09-11
Accepted Time:
2019-09-13 16:34:52
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1689813 Biohaven Pharmaceutical Holding Co Ltd. BHVN () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1262325 Eric Aguiar C/o Aisling Capital Llc
888 Seventh Avenue, 12Th Floor
New York NY 10106
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Acquisiton 2019-09-11 10,000 $25.51 10,000 No 4 M Indirect By Spouse
Common Shares Disposition 2019-09-11 10,000 $45.00 0 No 4 S Indirect By Spouse
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Indirect By Spouse
No 4 S Indirect By Spouse
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Shares Employee Stock Option (Right to Buy) Disposition 2019-09-11 10,000 $0.00 10,000 $25.51
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
20,000 2027-08-03 No 4 M Indirect
Footnotes
  1. These exercises and sales were made pursuant to a 10b5-1 trading plan adopted by the Reporting Person's spouse.
  2. The option, representing a right to purchase a total of 40,000 shares was granted on August 4, 2017, vesting in four equal installments on July 5, 2018, 2019, 2020 and 2021, subject to the optionholder's continuous service with the Issuer at each vesting date. The optionholder previously exercised the option with respect to 10,000 shares on February 4, 2019.
  3. This employee stock option is held by the Reporting Person's spouse.